Oura, the smart ring maker behind the Oura Ring, has officially filed to go public, marking a significant milestone for the wearable health technology sector. The company submitted its paperwork with the Securities and Exchange Commission on Thursday, revealing substantial revenue growth. This move signals the company’s confidence as it transitions from a privately held startup to a publicly traded entity. As Oura files IPO, investors and industry watchers are closely examining the company’s financial health, growth trajectory, and the competitive landscape it faces.
Impressive Revenue Growth and Sales Figures
The numbers in the filing show rapid business expansion. Oura’s revenue jumped from $697 million during the nine-month period ending June 30 last year to $1.2 billion in the same period this year. This represents a year-over-year increase of approximately 72%. The company has previously disclosed it generated $500 million in revenue for all of 2024, roughly $1 billion in 2025, and it expects to reach close to $2 billion in revenue by the end of this year. This trajectory is fueling investor interest as Oura files IPO.
The company states it has sold 3.6 million rings over the past year and currently maintains about 5 million paid members. These members subscribe to Oura’s service for access to broader health metrics, representing a recurring revenue stream that strengthens its business model. The filing also highlights an approximately 85% weighted-average 12-month membership retention rate, meaning that almost nine out of ten members who sign up in a given month remain subscribed a year later.
Understanding the Oura Ring Platform
Oura Ring devices sell in the range of $350 to $400. At their core, they are fitness trackers designed to measure user biometrics, including metabolism, heart rate, stress levels, and sleep patterns. The ring and its companion app are marketed as an “always-on health intelligence platform.” Unlike traditional smartwatches, the ring’s form factor allows for continuous, unobtrusive monitoring, which has appealed to health-conscious consumers seeking detailed wellness insights.
Late last month, reports indicated the company was aiming to raise $3 billion during its public offering. After a confidential filing in May, the company is now expected to seek a $16 billion valuation, up from its $11 billion valuation in October of last year. If successful, this would position Oura as one of the most valuable wearable technology companies in the public market.
Strategic Vision Beyond Fitness Tracking
In its SEC filing, Oura outlines where it believes its audience can widen in the coming years. “We believe our opportunity extends beyond traditional wearable use cases centered on activity and fitness tracking,” the company states. “We believe our platform can support significantly larger populations as we continue to expand access, build clinical evidence, and deepen integrations with health plans, employers, and care providers.”
This strategic direction moves Oura into the broader healthcare ecosystem, positioning its data as valuable for clinical and wellness applications. The company appears to be targeting partnerships with insurance providers and corporate wellness programs, which could open new revenue channels beyond direct consumer sales. As Oura files IPO, this expanded market opportunity is a key part of its growth narrative.
The AI Advantage and Biometric Data
A significant part of Oura’s pitch to investors is its proprietary data set. The company notes it has amassed “one of the largest and highest-quality longitudinal biometric datasets in consumer health,” tracking over 50 health and wellness metrics across nearly 42 billion hours of physiological data. This dataset powers the company’s AI and machine-learning models, which decode complex physiological patterns. As member histories deepen, the system aims to improve in accuracy, personalization, and predictive capability, making the technology more useful over time.
The company believes this data moat gives it a competitive advantage that would be difficult for new entrants to replicate. With artificial intelligence becoming increasingly central to health technology, Oura’s ability to leverage its dataset for predictive insights could differentiate it from competitors who rely on less comprehensive user data.
Legal Challenges and Consumer Criticism
While the financial news is positive, Oura is also facing a proposed class action lawsuit accusing it of misleading users about the accuracy of its sleep tracking capabilities. The suit alleges Oura’s rings cannot actually detect the physiological signals needed to determine sleep stages, instead relying on AI-generated estimates that the complaint describes as little more reliable than a coin flip. This litigation follows years of online complaints from users who said the device consistently rated their sleep as optimal when, in fact, it was not.
The company has disputed these allegations and previously told TechCrunch it will “defend against” the claims in the “appropriate legal forum.” For potential investors, this lawsuit represents a risk factor that could affect consumer trust and future sales. The outcome of this legal battle may have implications for how wearable health devices market their capabilities.
Competitive Landscape and Market Position
The wearable health technology market has become increasingly crowded, with competitors like Apple, Samsung, and Fitbit offering similar health tracking features. However, Oura’s ring form factor and focus on comprehensive health intelligence give it a distinct niche. The company’s emphasis on sleep tracking, recovery metrics, and readiness scores appeals to users seeking more than just step counting.
As Oura files IPO, it faces the challenge of justifying a high valuation in a competitive market. The company must demonstrate the uniqueness of its platform and data to potential investors. It also needs to address concerns about the accuracy of its health claims, which are central to its brand promise.
Global Presence and Company Background
The company, founded in Finland in 2013, now has offices throughout the world, including San Francisco. This international footprint reflects its global customer base and ambitions. The company’s transition from a Finnish startup to a potential public company represents a significant journey in the wearable technology space.
Outlook and What to Watch
The outcome of Oura’s IPO will likely influence the broader smart ring market and set a benchmark for other wearable health tech companies considering going public. With offices around the world and a growing subscriber base, Oura is positioning itself as a leader in the intersection of consumer electronics and health intelligence.
Investors will be watching several key factors as the IPO proceeds, including the final pricing of shares, institutional demand, and how the company addresses the pending lawsuit. The company’s ability to continue its revenue growth trajectory while managing legal and competitive risks will determine its success as a public company.
The IPO also raises questions about the future of wearable health technology. As Oura files IPO, it signals confidence in the long-term demand for health monitoring devices. However, the company must continue innovating to maintain its competitive edge in a market where consumer preferences and technology evolve rapidly.
